Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.
Crit Rev Oncol Hematol
; 129: 27-39, 2018 Sep.
Article
in En
| MEDLINE
| ID: mdl-30097235
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers
/
Carcinoma, Non-Small-Cell Lung
/
Patient Selection
/
B7-H1 Antigen
/
CTLA-4 Antigen
/
Lung Neoplasms
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Crit Rev Oncol Hematol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2018
Document type:
Article
Country of publication: